Signaling pathways mediating the response to hypertrophic stress in the heart

Gene Expression

Volumn 7, Issue 4-6, 1999, Pages 337-348

  Force, Thomas ^b   Hajjar, Roger ^b   Del Monte, Federica ^b   Rosenzweig, Anthony ^b   Choukroun, Gabriel ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

C Jun N terminal kinases; Cardiac hypertrophy; Heart failure; Stress activated protein kinases

Indexed keywords

CALCINEURIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR FACTOR; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR;

CONFERENCE PAPER; DISEASE ASSOCIATION; GENE TARGETING; HEART HYPERTROPHY; HUMAN; HYPERTENSION; MOLECULAR DYNAMICS; PATHOGENESIS; PATHOPHYSIOLOGY; PROTEIN DEFECT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0032773408     PISSN: 10522166     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (74)

1. Akhter, S. A.; Luttrell, L. M.; Rockman, H. A.; Iaccarino, G.; Lefkowitz, R. J.; Koch, W. J. Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280:574-577; 1998.
2. Beals, C. R.; Clipstone, N. A.; Ho, S. N.; Crabtree, G. R. Nuclear localization of NF-ATc by a calcineurindependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 11:824-834; 1997.
3. Bogoyevitch, M. A.; Gillespie-Brown, J.; Ketterman, A. J.; Fuller, S. J.; Ben-Levy, R.; Ashworth, A.; Marshall, C. J.; Sugden, P. H. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. Circ. Res. 79:162-173; 1996.
4. Bowman, J. C.; Steinberg, S. F.; Jiang, T.; Geenen, D. L.; Fishman, G. I.; Buttrick, P. M. Expression of protein kinase Cβ in the heart causes hypertrophy in adult mice and sudden death in neonates. J. Clin. Invest. 100:2189-2195; 1997.
5. Chen, L.; Glover, J. N. M.; Hogan, P. G.; Rao, A.; Harrison, S. C. Structure of the DNA-binding domains from NFAT, Fos, and Jun bound specifically to DNA. Nature 392:42-418; 1998.
6. Choukroun, G.; Hajjar, R.; Bonventre, J. V.; Kyriakis, J. M.; Rosenzweig, A.; Force, T. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy. J. Clin. Invest. 102:1311-1320;1998.
7. Choukroun, G.; Hajjar, R.; Rosenzweig, A.; Force, T. Regulation of cardiac hypertrophy in vivo by the stress-activated protein kinases/c-Jun N-terminal kinases. Circulation 98:1-69; 1998.
8. Cohen, P. The search for physiological substrates of mitogen- and stress-activated protein kinases in mammalian cells. Trends Cell Biol. 7:353-361; 1997.
9. D'Angelo, D. D.; Sakata, Y.; Lorenz, J. H.; Boivin, G. P.; Walsh, R. A.; Liggett, S. B.; Dorn, G. W. Transgenic Gaq overexpression induced cardiac contractile failure in mice. Proc. Natl. Acad. Sci. USA 94:8121-8126; 1997.
10. Fentzke, R. C.; Korcarz, C. E.; Lang, R. M.; Lin, H.; Leiden, J. M. Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J. Clin. Invest. 101:2415-2426; 1998.
11. Gille, H.; Sharrocks, A. D.; Shaw, P. E. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 358:414-416; 1992.
12. Gupta, S.; Campbell, D.; Derijard, B.; Davis, R. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393; 1995.
13. Hajjar, R. J.; Kang, J. X.; Gwathmey, J. K.; Rosenzweig, A. Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes. Circulation 95:423-429; 1997.
14. Hajjar, R. J.; Schmidt, U.; Kang, J. X.; Matsui, T.; Rosenzweig, A. Adenoviral gene transfer of phospholamban in isolated rat cardiomyocytes. Rescue effects by concomitant gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase. Circ. Res. 81:145-153; 1997.
15. Hajjar, R. J.; Schmidt, U.; Matsui, T.; Guerrero, L.; Lee, K. H.; Gwathmey, J. K.; Dec, G. W.; Semigran, M. J.; Rosenzweig, A. Modulation of ventricular function through gene transfer in vivo. Proc. Natl. Acad. Sci. USA 95:5251-5256; 1998.
16. Harada, K.; Komuro, I.; Zou, Y.; Kudoh, S.; Kijima, K.; Matsubara, H.; Sugaya, T.; Murakami, K.; Yazaki, Y. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type la knockout mice. Circ. Res. 82:779-785; 1998.
17. Harsdorf, R.; Edwards, J. G.; Shen, Y. T.; Kudej, R. K.; Dietz, R.; Leinwand, L. A.; Nadal-Ginard, B.; Vatner, S. F. Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J. Clin. Invest. 100:1294-1304; 1997.
18. Hasegawa, K.; Lee, S. J.; Jobe, S. M.; Markham, B. E.; Kitsis, R. N. cis-acting sequences that mediate induction of β-myosin heavy chain gene expression during left ventricular hypertrophy due to aortic constriction. Circulation 96:3943-3953; 1997.
19. Heasley, L. E.; Storey, B.; Fanger, G.; Butterfield, L.; Zamarripa, J.; Blumberg, D.; Maue, R. A. GTPase-deficient Gα16 and Gαq induce PC12 cell differentiation and persistent activation of c-Jun NH2-terminal kinases. Mol. Cell. Biol. 16:648-656; 1996.
20. Herzig, T. C.; Jobe, S. M.; Aoki, H.; Molkentin, J. D.; Cowley, A. W.; Izumo, S.; Markham, B. E. Angiotensin II type la receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overload. Proc. Natl. Acad. Sci. USA 94:7543-7548; 1997.
21. Hunter, J. J.; Tanaka, N.; Rockman, H. A.; Ross, J., Jr.; Chien, K. R. Ventricular expression of the MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J. Biol. Chem. 270:23173-23178; 1995.
22. James, J.; Robbins, J. Molecular remodeling of cardiac contractile function. Am. J. Physiol. 273:H2105-H118; 1997.
23. Karin, M. The regulation of AP-1 activity by mitogenactivated protein kinases. J. Biol. Chem. 270:16483-16486; 1995.
24. Klee, C. B.; Ren, H.; Wang, X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J. Biol. Chem. 273:13367-13370; 1998.
25. Komuro, I.; Yazaki, Y. Control of cardiac gene expression by mechanical stress. Annu. Rev. Physiol. 55:55-75; 1993.
26. Kovacic-Milivojevic, B.; Wong, V. S. H.; Gardner, D. G. Selective regulation of the atrial natriuretic peptide gene by individual components of the activator protein-1 complex. Endocrinology 137:1008-1117; 1996.
27. Livingstone, C.; Patel, G.; Jones, N. ATF2 contains a phosphorylation dependent transcriptional activation domain. EMBO J. 14:1785-1797; 1995.
28. Luo, Z.; Shyu, K.-G.; Gualberto, A.; Walsh, K. Calcineurin inhibitors and cardiac hypertrophy. Nat. Med. 4:1092-1093; 1998.
29. Mackay, D. J. G.; Hall, A. Rho GTPases. J. Biol. Chem. 273:20685-20688; 1998.
30. Matsuda, S.; Moriguchi, T.; Koyasu, S.; Nishida, E. T lymphocyte activation signals for interleukin-2 production involve activation of MKK6-p38 and MKK7-SAPK/JNK signaling pathways sensitive to cyclosporin A. J. Biol. Chem. 273:12378-12382; 1998.
31. McDonough, P. M.; Hanford, D. S.; Sprenkle, A. B.; Mellon, N. R.; Glembotski, C. C. Collaborative roles for c-Jun N-terminal kinase, c-Jun, serum response factor, and Spl in calcium-regulated myocardial gene expression. J. Biol. Chem. 272:24046-24053; 1997.
32. Mende, U.; Kagen, A.; Cohen, A.; Aramburu, J.; Schoen, F. J.; Neer, E. J. Transient cardiac expression of constitutively active Gαq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc. Natl. Acad. Sci. USA 95:13893-13898; 1998.
33. Miyamoto, M. I.; Guerrero, J. L.; Schmidt, U.; Gwathmey, J. K.; Dec, G. W.; Rosenzweig, A.; Hajjar, R. J. Adenoviral gene transfer of SERCA2a improves LV function in aortic-banded rats in transition to heart failure. Circulation 98:1-731; 1998.
34. Molkentin, J. D. Calcineurin inhibition and cardiac hypertrophy [response to letter]. Science 282:1007; 1998.
35. Molkentin, J. D.; Lu, J. R.; Antos, C. L.; Markham, B.; Richardson, J.; Robbins, J.; Grant, S. R.; Olson, E. N. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228; 1998.
36. Molkentin, J. D.; Olson, E. N. GATA4: A novel transcriptional regulator of cardiac hypertrophy? Circulation 96:3833-3835; 1997.
37. Morooka, H.; Bonventre, J. V.; Pombo, C. M.; Kyriakis, J. M.; Force, T. Ischemia and reperfusion enhance ATF-2 and c-Jun binding to cAMP response elements and to an AP-1 binding site from the c-jun promoter. J. Biol. Chem. 270:30084-30092; 1995.
38. Muller, J. G.; Nemoto, S.; Laser, M.; Carabello, B. A.; Menick, D. R. Calcineurin inhibition and cardiac hypertrophy [letter]. Science 282:1007; 1998.
39. Nemoto, S.; Zelin, S.; Lin, A. Opposing effects of Jun kinase and p38 mitogen-activated protein kinases on cardiomyocyte hypertrophy. Mol. Cell. Biol. 18:3518-3526; 1998.
40. Paradis, P.; MacLellan, W. R.; Belaguli, N. S.; Schwartz, R. J.; Schneider, M. D. Serum response factor mediates AP-1-dependent induction of the skeletal a actin promoter in ventricular myocytes. J. Biol. Chem. 271:10827-10833; 1996.
41. Parker, T. G.; Schneider, M. D. Peptide growth factor can provoke 'fetal' contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:507-514; 1990.
42. Pennica, D.; Shaw, K. J.; Swanson, T. A.; Moore, M. W.; Shelton, D. L.; Zioncheck, K. A.; Rosenthal, A.; Taga, T.; Paoni, N. F.; Wood, N. I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 complex. J. Biol. Chem. 270:10915-10922; 1995.
43. Post, G. R.; Goldstein, D.; Thuerauf, D. J.; Glembotski, C. C.; Brown, J. H. Dissociation of p44 and p42 mitogen-activated protein kinase activation from receptor-induced hypertrophy in neonatal rat ventricular myocytes. J. Biol. Chem. 271:8452-8457; 1996.
44. Pracyk, J. B.; Tanaka, K.; Hegland, D. D.; Kim, K. S.; Sethi, R.; Rovira, I. I.; Blazina, D. R.; Lee, L.; Bruder, J. T.; Kovesdi, I.; Goldschmidt-Clermont, P. U.; Irani, K.; Finkel, T. A requirement for the racl GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy. J. Clin. Invest. 102:929-937; 1998.
45. Pulverer, B.; Kyriakis, J. M.; Avruch, J.; Nikolakaki, E.; Woodgett, J. R. Phosphorylation of c-jun mediated by MAP kinases. Nature 353:670-674; 1991.
46. Ramirez, M. T.; Sah, V. P.; Zhao, X. L.; Hunter, J. J.; Chien, K. R.; Brown, J. H. The MEKK-JNK pathway is stimulated by α1-adrenergic receptor and Ras activation and is associated with in vitro and in vivo cardiac hypertrophy. J. Biol. Chem. 272:14057-14061; 1997.
47. 1 integrins participate in the hypertrophie response of rat ventricular myocytes. Circ. Res. 82:1160-1172; 1998.
48. Sadoshima, J.; Izumo, S. The cellular and molecular response of cardiac myocytes to mechanical stress. Annu. Rev. Physiol. 59:551-571; 1997.
49. Sadoshima, J.; Izumo, S. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Circ. Res. 77:1040-1052; 1995.
50. Sadoshima, J.; Xu, Y.; Slayter, H. S.; Izumo, S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 75:977-984; 1993.
51. Sakai, S.; Miyauchi, T.; Kobayashi, M.; Goto, K.; Sugishita, Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 385:353-355; 1996.
52. Sakata, Y.; Hoit, B. D.; Liggett, S. B.; Walsh, R. A.; Dorn, G. W. Decompensation of pressure-overload hypertrophy in Gαq-overexpressing mice. Circulation 97:1488-1495; 1998.
53. Shubita, H. E.; McDonough, P. M.; Harris, A. N.; Knowlton, K. U.; Glembotski, C. C.; Brown, J. H.; Chien, K. R. Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. J. Biol. Chem. 265:20555-20562; 1990.
54. Spirito, P.; Seidman, C. E.; McKenna, W. J.; Maron, B. J. The management of hypertrophie cardiomyopathy. N. Engl. J. Med. 336:775-785; 1997.
55. Su, B.; Jacinot, E.; Masahiko, H.; Kallunki, T.; Karin, M.; Ben-Neriah. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77:727-736; 1994.
56. Sugden, P.; Clerk, A. Stress-responsive mitogen-activated protein kinases (c-Jun N-terminal kinases and the p38 mitogen-activated protein kinases) in the myocardium. Circ. Res. 83:345-352; 1998.
57. Sussman, M. A.; Lim, H. W.; Gude, N.; Taigen, T.; Olson, E. N.; Robbins, J.; Colbert, M. C.; Gualberto, A.; Wieczorek, D. F.; Molkentin, J. D. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 281:1690-1693; 1998.
58. Tan, Y.; Rouse, J.; Zhang, A.; Cariati, S.; Cohen, P.; Comb, M. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAP-KAP kinase-2. EMBO J. 15:4629-4642; 1996.
59. Thorburn, A.; Thorburn, J.; Chen, S. Y.; Powers, S.; Shubeita, H. E.; Feramisco, J. R.; Chien, K. R. H-Ras dependent pathways can activate morphological and genetic markers of cardiac hypertrophy. J. Biol. Chem. 268:2244-2249; 1993.
60. Thorburn, J.; Carlson, M.; Mansour, S. J.; Chien, K. R.; Ahn, N. G.; Thorburn, A. Inhibition of a signaling pathway in cardiac muscle cells by active mitogen activated protein kinase kinase. Mol. Biol. Cell 6:1479-1490; 1995.
61. Thorburn, J.; Frost, J. A.; Thorburn, A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell Biol. 126:1565-1572; 1994.
62. Thorburn, J.; McMahon, M.; Thorburn, A. Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy. J. Biol. Chem. 269:30580-30586; 1994.
63. Thorburn, J.; Xu, S.; Thorburn, A. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells. EMBO J. 16:1888-1900; 1997.
64. Thuerauf, D. J.; Hanford, D. S.; Glembotski, C. C. Regulation of rat brain natriuretic peptide transcription. J. Biol. Chem. 269:17772-17775; 1994.
65. van Dam, H.; Wilhelm, D.; Herr, I.; Steffen, A.; Herrlich, P.; Angel, P. ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 14:1798-1811; 1995.
66. Van Heutgen, H. A. A.; Lamers, J. M. J. Changes in cardiac phenotype in hypertrophy and failure: From receptor to gene. Heart Failure Rev. 2:95-106; 1997.
67. Vikstrom, K. L.; Leinwand, L. A. Contractile protein mutations and heart disease. Curr. Opin. Cell Biol. 8:97-105; 1996.
68. Vojtek, A. B.; Der, C. J. Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273:19925-19928; 1998.
69. Wakasaki, H.; Koya, D.; Schoen, F. J.; Jirousek, M. R.; Ways, D. K.; Hoit, B. D.; Walsh, R. A.; King, G. L. Targeted overexpression of protein kinase C β2 isoform in myocardium causes cardiomyopathy. Proc. Natl. Acad. Sci. USA 94:9320-9325; 1997.
70. Wang, Y.; Huang, S.; Sah, V. P.; Ross, J.; Brown, J. H.; Han, J.; Chien, K. R. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J. Biol. Chem. 273:2161-2168; 1998.
71. Wang, Y.; Su, B.; Sah, V. P.; Brown, J. H.; Han, J.; Chien, K. R. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. 273:5423-5426; 1998.
72. Whitmarsh, A. J.; Yang, S.-H.; Su, M.-S.; Sharrocks, A. D.; Davis, R. J. Role of p38 and JNK mitogen-activated protein kinases in activation of ternary complex factors. Mol. Cell. Biol. 17:2360-2371; 1997.
73. Yamazaki, T.; Yazaki, Y. Is there a major involvement of the renin-angiotensin system in cardiac hypertrophy. Circ. Res. 81:639-642; 1997.
74. Zechner, D.; Thuerauf, D. J.; Hanford, D. S.; McDonough, P. M.; Glembotski, C. C. A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression. J. Cell Biol. 139:115-127; 1997.